View in EDS

Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.

Saved in:
Bibliographic Details
Title: Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
Authors: Yankelevich M; St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, USA yankelevic@gmail.com LGL4F@uvahealth.org.; Children's Hospital of Michigan, Detroit, Michigan, USA., Thakur A; University of Virginia Cancer Center, Charlottesville, Virginia, USA., Modak S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Chu R; Children's Hospital of Michigan, Detroit, Michigan, USA., Taub J; Children's Hospital of Michigan, Detroit, Michigan, USA., Martin A; Children's Hospital of Michigan, Detroit, Michigan, USA., Schalk D; University of Virginia Cancer Center, Charlottesville, Virginia, USA., Schienshang A; University of Virginia Cancer Center, Charlottesville, Virginia, USA., Whitaker S; University of Virginia Cancer Center, Charlottesville, Virginia, USA., Rea K; University of Virginia Cancer Center, Charlottesville, Virginia, USA., Lee DW; University of Virginia Cancer Center, Charlottesville, Virginia, USA., Liu Q; Wistar Institute, Philadelphia, Pennsylvania, USA., Shields AF; Karmanos Cancer Institute, Detroit, Michigan, USA., Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lum LG; University of Virginia Cancer Center, Charlottesville, Virginia, USA yankelevic@gmail.com LGL4F@uvahealth.org.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 21; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 21.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38519053
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yankelevich+M%22">Yankelevich M</searchLink>; St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, USA yankelevic@gmail.com LGL4F@uvahealth.org.; Children's Hospital of Michigan, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Thakur+A%22">Thakur A</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Modak+S%22">Modak S</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Chu+R%22">Chu R</searchLink>; Children's Hospital of Michigan, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Taub+J%22">Taub J</searchLink>; Children's Hospital of Michigan, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Martin+A%22">Martin A</searchLink>; Children's Hospital of Michigan, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Schalk+D%22">Schalk D</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Schienshang+A%22">Schienshang A</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Whitaker+S%22">Whitaker S</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Rea+K%22">Rea K</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Lee+DW%22">Lee DW</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Wistar Institute, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Shields+AF%22">Shields AF</searchLink>; Karmanos Cancer Institute, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Cheung+NV%22">Cheung NV</searchLink>; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lum+LG%22">Lum LG</searchLink>; University of Virginia Cancer Center, Charlottesville, Virginia, USA yankelevic@gmail.com LGL4F@uvahealth.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2024 Mar 21; Vol. 12 (3). <i>Date of Electronic Publication: </i>2024 Mar 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38519053
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2023-008744
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yankelevich M
      – PersonEntity:
          Name:
            NameFull: Thakur A
      – PersonEntity:
          Name:
            NameFull: Modak S
      – PersonEntity:
          Name:
            NameFull: Chu R
      – PersonEntity:
          Name:
            NameFull: Taub J
      – PersonEntity:
          Name:
            NameFull: Martin A
      – PersonEntity:
          Name:
            NameFull: Schalk D
      – PersonEntity:
          Name:
            NameFull: Schienshang A
      – PersonEntity:
          Name:
            NameFull: Whitaker S
      – PersonEntity:
          Name:
            NameFull: Rea K
      – PersonEntity:
          Name:
            NameFull: Lee DW
      – PersonEntity:
          Name:
            NameFull: Liu Q
      – PersonEntity:
          Name:
            NameFull: Shields AF
      – PersonEntity:
          Name:
            NameFull: Cheung NV
      – PersonEntity:
          Name:
            NameFull: Lum LG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 03
              Text: 2024 Mar 21
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1